MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
37 hedge funds and large institutions have $14.1M invested in Merrimack Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
-11
Holders Change %
-22.92%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
12
Closed
12
Calls
$58K
Puts
$55K
Net Calls
+$3K
Net Calls Change
+$57K
Top Buyers
1 |
Victory Capital Management
San Antonio,
Texas
|
+$10K |
2 |
UBS Group
Zurich,
Switzerland
|
+$4.61K |
3 |
![]()
JPMorgan Chase & Co
New York
|
+$1.58K |